MLYS vs PHM · $2.17B cap vs P/E 7.7, rev $7.39B
Mineralys Therapeutics, Inc. Common Stock (MLYS) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
MLYS does not have a complete income-statement cache yet.
Latest reported PHM revenue for 2026-06-30 was $7.39B. Net income was $819.0M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
MLYS currently screens at market cap $2.17B. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the MLYS and PHM stock pages for the full models.
Not investment advice.